These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6661217)

  • 21. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fate of epoxides.
    Oesch F
    Adv Exp Med Biol; 1981; 136 Pt A():39-52. PubMed ID: 7046377
    [No Abstract]   [Full Text] [Related]  

  • 23. Resolution of epoxide enantiomers of polycyclic aromatic hydrocarbons by chiral stationary-phase high-performance liquid chromatography.
    Weems HB; Mushtaq M; Yang SK
    Anal Biochem; 1985 Aug; 148(2):328-38. PubMed ID: 4061813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzofluoranthenes: calculated diol epoxide reactivities.
    Silverman BD; Lowe JP
    Chem Biol Interact; 1983 Dec; 47(3):289-92. PubMed ID: 6652812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Covalent intercalative binding to DNA in relation to the mutagenicity of hydrocarbon epoxides and N-acetoxy-2-acetylaminofluorene.
    Drinkwater NR; Miller JA; Miller EC; Yang NC
    Cancer Res; 1978 Oct; 38(10):3247-55. PubMed ID: 356963
    [No Abstract]   [Full Text] [Related]  

  • 26. METABOLISM OF POLYCYCLIC COMPOUNDS. THE METABOLISM OF 9,10-EPOXY-9,10-DIHYDROPHENANTHRENE IN RATS.
    BOYLAND E; SIMS P
    Biochem J; 1965 Jun; 95(3):788-92. PubMed ID: 14342516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding P450-mediated Bio-transformations into Epoxide and Phenolic Metabolites.
    Tomberg A; Pottel J; Liu Z; Labute P; Moitessier N
    Angew Chem Int Ed Engl; 2015 Nov; 54(46):13743-7. PubMed ID: 26418278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of subdomain IB in human serum albumin as a major binding site for polycyclic aromatic hydrocarbon epoxides.
    Brunmark P; Harriman S; Skipper PL; Wishnok JS; Amin S; Tannenbaum SR
    Chem Res Toxicol; 1997 Aug; 10(8):880-6. PubMed ID: 9282837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Occurrence, biosynthesis and metabolism of substances with epoxide structure].
    Voigt S; Luckner M
    Pharmazie; 1978 Oct; 33(10):632-9. PubMed ID: 364492
    [No Abstract]   [Full Text] [Related]  

  • 30. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons.
    Shimada T; Martin MV; Pruess-Schwartz D; Marnett LJ; Guengerich FP
    Cancer Res; 1989 Nov; 49(22):6304-12. PubMed ID: 2509067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,4-Reductive addition of glutathione to quinone epoxides. Mechanistic studies with h.p.l.c. with electrochemical detection under anaerobic and aerobic conditions. Evaluation of chemical reactivity in terms of autoxidation reactions.
    Brunmark A; Cadenas E
    Free Radic Biol Med; 1989; 6(2):149-65. PubMed ID: 2707617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical strategies for the inactivation of bay-region diol epoxides, ultimate carcinogens derived from polycyclic aromatic hydrocarbons.
    Sayer JM; Whalen DL; Jerina DM
    Drug Metab Rev; 1989; 20(2-4):155-82. PubMed ID: 2680377
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review.
    Xue W; Warshawsky D
    Toxicol Appl Pharmacol; 2005 Aug; 206(1):73-93. PubMed ID: 15963346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epoxide to olefin: a novel biotransformation in the rumen.
    Ivie GW
    Science; 1976 Mar; 191(4230):959-61. PubMed ID: 1251209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epoxides as reactive intermediates in aromatic hydrocarbon metabolism.
    Sims P
    Biochem Soc Trans; 1975; 3(1):59-62. PubMed ID: 1126542
    [No Abstract]   [Full Text] [Related]  

  • 37. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
    Wood AW; Wislocki PG; Chang RL; Levin W; Lu AY; Yagi J; Hernandez O; Herina DM; Conney AH
    Cancer Res; 1976 Sep; 36(9 pt.1):3358-66. PubMed ID: 788899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic transformation of clinically used drugs to epoxides: new perspectives in drug-drug interactions.
    Oesch F
    Biochem Pharmacol; 1976 Sep; 25(17):1935-7. PubMed ID: 985529
    [No Abstract]   [Full Text] [Related]  

  • 39. The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers.
    Monks TJ; Jones DC
    Curr Drug Metab; 2002 Aug; 3(4):425-38. PubMed ID: 12093358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic analysis of the metabolism of benzo(a)pyrene to phenols, dihydrodiols, and quinones by high-pressure chromatography compared to analysis by aryl hydrocarbon hydroxylase assay, and the effect of enzyme induction.
    Yang SK; Selkirk JK; Plotkin EV; Gelboin HV
    Cancer Res; 1975 Dec; 35(12):3642-50. PubMed ID: 1192425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.